Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Potential use of MLN-518 in AML and high-risk MDS

Dec. 13, 2002

Paladin returns Canadian DepoCyt rights to SkyePharma

Dec. 13, 2002

TLK-286 enters two new combination trials

Dec. 13, 2002

Telomerase inhibitors under study at Pharmacia

Dec. 13, 2002

Inhibition of Src tyrosine kinases as a novel approach to the treatment of CML

Dec. 12, 2002

Exherin cleared to enter phase I trials in Canada

Dec. 12, 2002

NanoCarrier and Kirin collaborate on anticancer therapeutics

Dec. 12, 2002

Apomine as a new therapeutic approach to multiple myeloma

Dec. 12, 2002

New caspase activators in Cytovia development pipeline

Dec. 12, 2002

Pipecolinate MDR modulators effective in modulating mitoxantrone efflux from AML cells

Dec. 11, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 4, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...